Abstract
To present the findings in a randomized, parallel-group study, comparing once-daily insulin glargine with twice-daily NPH insulin in patients with type 1 diabetes previously treated with multiple daily injections of basal and regular insulin. Of 394 patients with type 1 diabetes treated for up to 28 weeks, 195 received insulin glargine and 199 received NPH insulin, in addition to preprandial regular insulin. Glycemic control and hypoglycemic episodes were assessed. A greater mean decrease in fasting blood glucose (FBG) was achieved at endpoint with insulin glargine than with NPH insulin (-21 mg/dL versus -10 mg/dL [-1.17 mmol/L versus -0.56 mmol/L]; P = 0.015), and a greater percentage of patients treated with insulin glargine reached the target FBG (32.6% versus 21.3%; P = 0.015). Similar percentages of patients in both treatment groups achieved glycosylated hemoglobin values of 7.0% or less at endpoint (insulin glargine, 35.8%; NPH insulin, 35.4%). After the 1-month titration phase, the percentage of patients who reported at least one symptomatic hypoglycemic event confirmed by a blood glucose value of less than 50 mg/dL (2.8 mmol/L) was significantly lower with insulin glargine than with NPH insulin (73.3% versus 81.7%; P = ...Continue Reading
References
Mar 1, 1992·Diabetologia·I Swenne
Mar 1, 1982·Diabetes Care·M BergerP Berchtold
May 1, 1995·Diabetes Research and Clinical Practice·Y OhkuboM Shichiri
Jul 1, 1994·Diabetes Care·P E CryerH Shamoon
Dec 1, 1993·Diabetes Care·P E Cryer
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Mar 1, 1997·Diabetes Care·R HellmanH Rosen
Jul 9, 1999·Biopolymers·H Berchtold, R Hilgenfeld
Jun 2, 2000·Diabetes Care·R E RatnerC A Wilson
Jun 2, 2000·Diabetes Care·L HeinemannT Heise
Jun 27, 2000·Diabetes Care·T R PieberE Derobert
Aug 11, 2000·Diabetes Care·H Yki-JärvinenUNKNOWN HOE 901/300s Study Group
Aug 11, 2000·Diabetes Care·J RosenstockUNKNOWN U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group
Nov 25, 2000·Diabetes Care·P RaskinT Mecca
Dec 16, 2000·Diabetes·M LeporeG B Bolli
Apr 24, 2001·Diabetes Care·J RosenstockM B Edwards
Dec 28, 2002·Diabetes Care·UNKNOWN American Diabetes Association
May 8, 2003·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M Massi BenedettiM Ziemen
Citations
Oct 26, 2010·Diabetes Technology & Therapeutics·Satish GargAnastasia Rodionova
Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sumeet R SinghHeather Bennett
Mar 4, 2009·Pediatrics·Soumya AdhikariPerrin C White
Jan 1, 2007·Core Evidence·Rhian Clissold, Steve Clissold
Feb 27, 2007·Vascular Health and Risk Management·Anthony H Barnett
Aug 7, 2009·Wiener klinische Wochenschrift·Bernhard LudvikUNKNOWN Expertengruppe der Osterreichischen Diabetesgesellschaft
Mar 3, 2009·Medicina clínica·Arturo Lisbona Gil, Pedro Conthe Gutiérrez
Jul 1, 2008·The Journal of Pediatrics·H Peter ChaseWilliam V Tamborlane
Jul 1, 2008·Diabetes Research and Clinical Practice·Tsutomu WadaToshiyasu Sasaoka
Apr 17, 2008·Journal of Diabetes and Its Complications·A Enrique Caballero
Oct 9, 2007·Clinical Therapeutics·Peter MullinsHans-Ulrich Haring
Jun 15, 2006·The Diabetes Educator·Carolyn Robertson
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Moshe VardiHaim Bitterman
Aug 2, 2007·Diabetes/metabolism Research and Reviews·J H DevriesT R Pieber
Jul 25, 2007·Diabetes, Obesity & Metabolism·T Heise, T R Pieber
Jun 28, 2011·Diabetes Technology & Therapeutics·Stuart LittlePhilip Home
Sep 1, 2007·Expert Review of Endocrinology & Metabolism·Cecilia M Lansang, Laurence Kennedy
Aug 12, 2006·Journal of Child Neurology·Maria J HenwoodAdda Grimberg
Mar 29, 2006·Diabetes Care·Zachary T Bloomgarden
Nov 24, 2006·American Journal of Therapeutics·Athena Philis-TsimikasChris Walker
Mar 5, 2021·The Cochrane Database of Systematic Reviews·Bianca HemmingsenBernd Richter
Dec 25, 2008·Diabetes Care·Neil H WhiteUNKNOWN 4030 Study Group